Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2017	Apr. 02, 2016
Cash flows from operating activities:
Net income	$ 7,398	$ 2,663
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	71,114	72,256
Loss/(gain) on disposal of property, plant, equipment and other assets	(125)	698
Deferred taxes	(8,454)	(3,705)
Increase/(decrease) in long-term pension liability	702	(1,146)
Stock-based compensation expense	6,732	2,440
Deferred loan cost amortization	2,176	2,794
Equity in net income of unconsolidated subsidiaries	(706)	(5,643)
Distributions of earnings from unconsolidated subsidiaries	25,000	0
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(753)	7,118
Income taxes refundable/payable	7,576	400
Inventories and prepaid expenses	(10,660)	(21,206)
Accounts payable and accrued expenses	(8,365)	3,336
Other	2,834	(14,962)
Net cash provided by operating activities	94,469	45,043
Cash flows from investing activities:
Capital expenditures	(62,292)	(53,375)
Acquisitions, net of cash acquired	0	(8,511)
Investment in unconsolidated subsidiary	(2,250)	0
Gross proceeds from disposal of property, plant and equipment and other assets	1,340	1,424
Proceeds from insurance settlement	3,301	1,181
Net cash used by investing activities	(59,901)	(59,281)
Cash flows from financing activities:
Proceeds from long-term debt	8,649	8,760
Payments on long-term debt	(9,265)	(16,207)
Borrowings from revolving credit facility	47,000	33,000
Payments on revolving credit facility	(52,327)	(21,000)
Net cash overdraft financing	(1,077)	0
Deferred loan costs	(1,135)	0
Issuance of common stock	22	45
Repurchase of treasury stock	0	(5,000)
Minimum withholding taxes paid on stock awards	(1,995)	(1,788)
Excess tax benefits from stock-based compensation	0	(446)
Distributions to noncontrolling interests	(433)	0
Net cash used by financing activities	(10,561)	(2,636)
Effect of exchange rate changes on cash	309	7,316
Net increase/(decrease) in cash and cash equivalents	24,316	(9,558)
Cash and cash equivalents at beginning of period	114,564	156,884
Cash and cash equivalents at end of period	138,880	147,326
Supplemental disclosure of cash flow information:
Accrued capital expenditures	(2,787)	(6,595)
Cash paid during the period for:
Interest, net of capitalized interest	19,022	20,597
Income taxes, net of refunds	2,429	5,114
Debt issued for assets	0	10
Contribution of assets to unconsolidated subsidiary	$ 0	$ 2,674